MUHC offers immunocellular therapy for patients with leukemia or lymphoma | McGill University Health Centre
Treatment uses modified white blood cells to target cancer cells that are resistant to standard therapies.
Source: muhc.ca
📰 Michael Sebag News
Michael Sebag News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Sebag. Real-time updates on events, politics, business and more.